American College of Cardiology

OCTOBER 1, 2024

The tricuspid valve has historically received less attention compared to the valves on the left side of the heart. Tricuspid valve disease, however, is more common than previously thought, and if left untreated, it poses a significant risk of morbidity and mortality.

Tricuspid 43

Tricuspid Article 43

All About Cardiovascular System and Disorders

MARCH 30, 2024

Transcipt of video: Mild tricuspid regurgitation is often noted on echocadiogram reports and sometimes causes a little bit of worry and a lot of questions are asked on mild tricuspid regurgitation. What is this mild tricuspid regurgitation? And mild tricuspid regurgitation is just a small leak from the tricuspid valve.

Tricuspid 52

Tricuspid Echocardiogram Bicuspid/Mitral Pulmonary 52

American College of Cardiology

AUGUST 31, 2024

trial was to assess the efficacy and safety of tricuspid transcatheter edge-to-edge repair (T-TEER) + guideline-directed medical therapy (GDMT) compared with GDMT alone among patients with symptomatic ≥ severe tricuspid regurgitation (TR). The goal of the TRI.Fr

Tricuspid 43

Tricuspid Article 43

DAIC

APRIL 25, 2024

milla1cf Thu, 04/25/2024 - 17:21 April 25, 2024 — Atlantic Health System ’s Morristown Medical Center treated the first patient in New Jersey using Edwards Lifesciences EVOQUE tricuspid valve replacement, the first transcatheter therapy to receive U.S. According to National Institutes of Health an estimated 1.6 million people in the U.S.

Tricuspid 111

Tricuspid Quality of Life Hospital Nursing 111

DAIC

FEBRUARY 2, 2024

Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Heart Failure 100

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. the Roger L.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

Med Page Today

AUGUST 31, 2024

(MedPage Today) -- LONDON -- Tricuspid transcatheter edge-to-edge repair (T-TEER) improved how well patients functioned and felt without major cardiovascular events in the first academic randomized trial to affirm the pivotal trial findings.

Tricuspid 52

Tricuspid Academic 52

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

American College of Cardiology

OCTOBER 1, 2024

Our cover story this month, which outlines the issues surrounding tricuspid valve (TV) dysfunction, is worth a careful read. The story highlights the etiology, diagnosis and recent evolution of treatment strategies for TV dysfunction – medical, surgical and interventional.

Tricuspid 40

Tricuspid Article 40

CardiacWire

FEBRUARY 4, 2024

Edwards Lifesciences ended last week with the biggest structural interventions launch that we’ve seen in some time, announcing the FDA approval of its EVOQUE transcatheter tricuspid valve replacement system (TTVR). The post Edwards EVOQUE First FDA-Approved Transcatheter Tricuspid Regurgitation Treatment appeared first on Cardiac Wire.

Tricuspid 59

Tricuspid Quality of Life Medicare 59

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

By contrast, the right-sided diseases, particularly the tricuspid valve (TV) and associated regurgitation, still have much to be delineated. Worsening tricuspid regurgitation (TR) is associated with increased mortality; the non-invasive management is suboptimal; and surgical approaches carry significant risk.

Tricuspid 69

Tricuspid Anatomy Heart Disease 69

All About Cardiovascular System and Disorders

MARCH 30, 2024

In Ebstein’s anomaly, there is downward or apical displacement of posterior and septal tricuspid leaflets. The anterior leaflet is not displaced, but is elongated to meet the other leaflets, so that when it closes, a loud sound, tricuspid sound, is produced, which is called as the sail sound.

Tricuspid 52

Tricuspid Arrhythmia Congenital Heart Disease Electrophysiology 52

American College of Cardiology

JULY 17, 2024

What is the effect of a transvenous implantable cardioverter-defibrillator (TV-ICD) on tricuspid regurgitation (TR) severity, and secondarily, on right ventricular (RV) size and function?

Tricuspid 63

Tricuspid Defibrillator Article 63

Med Page Today

FEBRUARY 12, 2024

(MedPage Today) -- FDA staff questioned the evidence for clinical benefit with the TriClip G4 transcatheter edge-to-edge repair (TEER) system for severe tricuspid regurgitation (TR) in documents released ahead of the agency's Circulatory System.

Tricuspid 69

Tricuspid Document 69

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

Circulation

APRIL 25, 2024

Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease. Circulation, Ahead of Print.

Tricuspid 80

Tricuspid Pacemaker Heart Failure Pulmonary 80

Frontiers in Cardiovascular Medicine

JUNE 12, 2024

BackgroundSevere tricuspid regurgitation (TR) causing cyanosis with patent foramen ovale (PFO) and right-to-left atrial shunting requires a precise diagnosis for optimal therapy. Tricuspid valve prolapse (TVP) can lead to TR and is sometimes overlooked, especially in complex cases with factors like pulmonary hypertension (PH).

Tricuspid 52

Tricuspid Pulmonary Echocardiogram Hypertension 52

American College of Cardiology

AUGUST 5, 2024

What are the 1-year clinical outcomes of subjects treated by tricuspid transcatheter edge-to-edge repair (T-TEER) with the TriClip system in a contemporary real-world setting?

Tricuspid 46

Tricuspid Outcomes Article 46

Frontiers in Cardiovascular Medicine

AUGUST 8, 2024

We provide an overview about the current landscape of transcatheter tricuspid valve interventions (TTVI) and summarize recent findings from trials including TRILUMINATE, TRILUMINATE Pivotal, bRIGHT, TRICLASP, TRISCEND, TRISCEND II, TRICUS, and Cardioband TR EFS. These studies have demonstrated the safety and efficacy of TTVI.

Tricuspid 52

Tricuspid Quality of Life 52

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after one year, according to research presented in a Hot Line session August 31 at ESC Congress 2024.

Tricuspid 40

Tricuspid Quality of Life Research 40

Med Page Today

FEBRUARY 14, 2024

(MedPage Today) -- FDA advisors were nearly unanimous in backing the TriClip G4 transcatheter edge-to-edge repair (TEER) device as a treatment for severe tricuspid regurgitation (TR). During an advisory committee meeting on Tuesday, the FDA's.

Tricuspid 64

Tricuspid 64

European Journal of Heart Failure

MARCH 7, 2024

Changes in right ventricular (RV) function and clinical outcomes after tricuspid transcatheter edge-to-edge repair (T-TEER). Among patients with baseline RVFAC <35%, a smaller RV diameter and a greater reduction of tricuspid regurgitation were predictors for the RV responder.

Tricuspid 76

Tricuspid Outcomes Heart Failure Hospital 76

HCPLive

FEBRUARY 14, 2024

FDA advisory committee votes 13-1 that the benefits outweigh the risk of use for Abbott's TriClip for tricuspid regurgitation, pending FDA decision expected in 2024.

Tricuspid 59

Tricuspid 59

American College of Cardiology

DECEMBER 12, 2023

What are the predictors of tricuspid regurgitation (TR) progression and the prognostic impact of TR progression?

Tricuspid 64

Tricuspid Article 64

American College of Cardiology

APRIL 29, 2024

The following are key points to remember from an American Heart Association scientific statement, which reviews the pathology, imaging, and current treatment options for the tricuspid valve (TV).

Tricuspid 53

Tricuspid Article 53

American College of Cardiology

MARCH 25, 2024

The following are key points to remember from a state-of-the-art review about the current status and perspectives on transcatheter treatment of the tricuspid valve (TV).

Tricuspid 48

Tricuspid Article 48

American College of Cardiology

MARCH 18, 2024

In this episode, the focus is on tricuspid valve disease. In this panel discussion, host Andrea Price MS, AACC brings together Marcus Burns, DNP, Kristen deAlmeida, PharmD, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease.

Tricuspid 53

Tricuspid Allied Health Best Practices Nursing 53

Heart BMJ

FEBRUARY 23, 2024

Significant secondary tricuspid regurgitation (STR) has increasing prevalence with age, it is associated with impaired quality of life, and it is an independent predictor of patients’ morbidity and mortality. 3 4 However, the association of RA function with outcomes in patients with STR received less attention.

Tricuspid 74

Tricuspid Quality of Life Outcomes 74

HeartRhythm

APRIL 30, 2024

Tricuspid valve (TV) function and its relation to cardiac device implantation is an essential consideration. Recent studies have shown a 5% increase in prevalence of moderate to severe tricuspid valve regurgitation (TR) one year post endocardial lead implantation.

Tricuspid 40

Tricuspid Heart Failure Hospital 40

HeartRhythm

APRIL 30, 2024

Severe Tricuspid Regurgitation (TR) is associated with increased mortality. Change in TR severity with transvenous pacemaker (PPM) and implantable cardioverter defibrillator lead extraction has been poorly studied.

Tricuspid 40

Tricuspid Defibrillator Pacemaker 40

HCPLive

APRIL 2, 2024

Less than 2 months after being the subject of an FDA AdComm meeting, Abbott's TriClip TEER System has received approval for tricuspid regurgitation.

Tricuspid 40

Tricuspid 40

American College of Cardiology

FEBRUARY 26, 2024

What are survival rates after surgical or transcatheter intervention compared to conservative management based on tricuspid regurgitation (TR) clinical stage assessed using TRI-SCORE?

Tricuspid 43

Tricuspid Article 43

European Journal of Heart Failure

DECEMBER 22, 2023

Abstract Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death.

Heart Failure 75

Heart Failure Tricuspid Cardiovascular Interventions Quality of Life 75

Cardiovascular Ultrasound

SEPTEMBER 14, 2023

Accurate sizing of the tricuspid valve annulus is essential for determining the optimal timing of tricuspid valve (TV) intervention. Two-dimensional (2D) echocardiography has limitations for comprehensive TV a.

Tricuspid 40

Tricuspid Research 40

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Topaz is an innovative, minimally invasive device designed specifically to help patients suffering from severe TR, without the need for open heart surgery.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59

HeartRhythm

APRIL 30, 2024

Tricuspid valve (TV) disease associated with right ventricular leads has been linked to tricuspid leaflet restriction, resulting in worsening tricuspid regurgitation (TR).

Tricuspid 40

Tricuspid Outcomes 40

HeartRhythm

JULY 22, 2024

Although the electrcardiographic and electrophysiological properties of ventricular arrhythmias (VA) from the vicinity of lateral tricuspid annulus (TA) have been reported in previous studies, their precise site of origin have not been addressed.

Tricuspid 40

Tricuspid Arrhythmia Electrophysiology 40